An Unusual Case of Anti-FGFR3 Antibodies, Sensory Neuropathy, and Adie Pupil in a Patient With Hodgkin Lymphoma in Remission and Review of the Literature.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: anti-FGFR3 antibodies
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
In addition to the case report, we provide a review of the literature on anti-FGFR3-positive sensory neuropathy. To our knowledge, this is the first report of Adie pupil in a patient with anti-FGFR3 antibodies.
Autoantibodies against fibroblast growth factor receptor 3 (FGFR3) are associated with sensory neuropathy.
APA
Peters S, Whitt W, Lizarraga AA (2026). An Unusual Case of Anti-FGFR3 Antibodies, Sensory Neuropathy, and Adie Pupil in a Patient With Hodgkin Lymphoma in Remission and Review of the Literature.. Journal of clinical neuromuscular disease, 27(3), 99-104. https://doi.org/10.1097/CND.0000000000000545
MLA
Peters S, et al.. "An Unusual Case of Anti-FGFR3 Antibodies, Sensory Neuropathy, and Adie Pupil in a Patient With Hodgkin Lymphoma in Remission and Review of the Literature.." Journal of clinical neuromuscular disease, vol. 27, no. 3, 2026, pp. 99-104.
PMID
41766078 ↗
Abstract 한글 요약
Autoantibodies against fibroblast growth factor receptor 3 (FGFR3) are associated with sensory neuropathy. In this report, we describe the case of a woman with a remote history of Hodgkin lymphoma in remission who presented with unilateral Adie pupil, trigeminal neuropathy, and progressive sensory neuropathy. After 3 years without a known etiology and slow progression of symptoms, a trial of intravenous immunoglobulin (IVIg) was initiated and she subsequently tested positive for anti-FGFR3 antibodies. Despite the delay in treatment, she showed significant improvement with maintenance monthly IVIg therapy. In addition to the case report, we provide a review of the literature on anti-FGFR3-positive sensory neuropathy. To our knowledge, this is the first report of Adie pupil in a patient with anti-FGFR3 antibodies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
- SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in G12C NSCLC.
- Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study.
- Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study.
- Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.